1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
JINS HOLDINGS Inc.

JINS HOLDINGS Inc.

JNDOF
JINS HOLDINGS Inc.US flagOther OTC
47.22
USD
- -
- -
1.10BMarket Cap
JINS HOLDINGS Inc.
JNDOF
(Other OTC)

Recent

price

47.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
517.77
711.72
1,093.7
1,524.58
1,507.74
1,697.41
1,926.43
2,104.18
2,288.57
2,581.4
2,552.73
2,737.68
2,866.34
3,138.97
3,556.82
4,165.07
- -
Revenue per Share
11.35
18.75
52.69
142.61
51.93
79.33
82.58
115.4
129.17
161.37
71.47
141.04
32.13
75.49
200.17
356.89
- -
Basic EPS, GAAP
32.06
-29.37
-32.53
87.03
6.35
82.21
24.57
185.93
104.35
191.27
218.72
133.97
50.6
105.4
358.43
218.33
- -
Free Cash Flow per Basic Share
1
1.99
3.95
9.96
39.91
9.97
15.97
24.98
35.95
47.96
50.71
49.96
36.97
12.98
45.21
92.07
- -
Dividend per Share
84.99
101.75
279.32
373.49
385.42
442.27
508.87
599.29
692.47
806.41
839.81
940.39
935.08
997.55
1,115.06
1,379.49
- -
Book Value per Share
107.23
117.94
421.09
477.18
478.58
536.69
568.85
652.64
744.85
843.2
657.61
770.09
780.16
847.72
987.99
1,116.68
- -
Tangible Book Value per Share
20
20
21
24
24
24
24
24
24
24
24
23
23
23
23
23
- -
Basic Weighted Avg Shares
10,604
14,575
22,614
36,554
36,150
40,698
46,189
50,451
54,872
61,893
60,258
63,898
66,901
73,264
82,999
97,215
64,833
Sales/Revenue/Turnover
7.32
7.43
11.65
17.02
8.22
8.81
7.98
10.71
11.06
12.05
9.32
7.9
4.96
6.62
9.44
12.44
10.41
Operating Margin (%)
276
429
732
1,138
1,501
1,844
2,160
2,217
2,369
2,529
2,833
2,695
2,950
2,918
2,926
2,946
- -
Depreciation Expense
233
384
1,090
3,419
1,245
1,902
1,980
2,767
3,097
3,869
1,687
3,292
750
1,762
4,671
8,330
4,092
Net Income, GAAP
54.85
55.43
49.46
39.46
45.7
42.3
40.53
38.01
36.91
37.98
54.17
24.68
64.32
38.9
35.13
28.35
33.84
Effective Tax Rate (%)
2.19
2.63
4.82
9.35
3.44
4.67
4.29
5.48
5.64
6.25
2.8
5.15
1.12
2.41
5.63
8.57
6.31
Profit Margin (%)
307
235
6,091
6,276
3,490
4,104
4,854
6,369
7,039
9,065
22,266
22,704
10,475
12,487
6,591
6,933
- -
Working Capital
570
1,243
2,067
1,742
1,843
1,933
3,003
2,687
2,041
1,942
21,128
20,732
10,473
10,241
214
117
- -
LT Debt
2,236
2,578
8,953
12,132
12,419
13,979
15,232
17,515
19,707
22,370
17,763
20,218
20,405
21,777
25,593
31,741
- -
Total Equity
10.01
11.04
14.03
23.73
9.14
11.01
10.43
14.34
15.25
16.93
6.9
8.4
2.64
7.4
13.35
21.41
26.26
Return on Invested Capital (%)
8.64
11.23
15.96
30.96
9.87
13.72
12.28
15.09
15.62
17.63
5.17
7.62
1.79
4.6
12.82
22.12
23.6
Return on Capital (%)
14.23
20.08
27.73
46.43
13.69
19.17
17.36
20.83
20
21.53
8.62
15.76
3.43
7.81
18.95
28.62
35.06
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'24
Aug'24
Nov'25
ST Debt
11,777
12,159
- -
LT Borrowings
26
24
- -
LT Finance Leases
- -
190
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
- -
Market Capitalization
82,917
77,641
- -

Working Capital

FRC

•

in mil. unless spec.
May'24
Aug'24
Nov'25
Total Current Assets
27,080
32,254
- -
Cash, Cash Equivalents & STI
13,737
18,673
- -
Accounts Receivable, Net
5,970
6,572
- -
Inventories
5,610
5,106
- -
Total Current Liabilities
22,523
25,663
- -
Payables & Accruals
- -
- -
- -
ST Debt
11,777
12,159
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.24%
12.6%
24.02%
Free Cash Flow
84.63%
41.51%
-39.07%
Net Income, GAAP
42.06%
79.26%
78.33%
Sales/Revenue/Turnover
9.23%
10.13%
17.13%
Total Cash Common Dividend
45.65%
51.68%
103.7%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
18,166
19,852
21,145
23,836
82,999
2025
- -
- -
- -
- -
97,215
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24.81
- -
- -
- -
200.17
2025
- -
- -
- -
- -
356.89
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
45.21
2025
- -
- -
- -
- -
92.07
2026
- -
- -
- -
- -
- -
Similar Companies
Baxter International Inc. (0QK8.L)
Ligua Inc. (7090.T)
Sanara MedTech Inc. (SMTI)
Mercator Medical S.A. (MRC.WA)
BenQ Medical Technology Corporation (4116.TWO)
Straumann Holding AG (STMN.SW)
Business
JINS HOLDINGS Inc., a prominent Japanese entity established in 1988, oversees the comprehensive design, production, and retail of eyewear and related accessories across various international markets. Operating predominantly under the widely recognized JINS brand, the company's product line features a diverse selection of prescription and non-prescription spectacles, including functional options like JINS SCREEN for blue light reduction, adaptable JINS Switch magnetic eyewear, and specialized children’s glasses. Additionally, the firm offers JINS VIOLET lenses for specific light filtration and the innovative JINS MEME, which monitors physical and mental states through integrated sensors, alongside JINS 1DAY contact lenses. This extensive range is distributed through a substantial network of physical stores, including flagship locations and numerous other retail points, bolstered by a robust online sales presence. JINS HOLDINGS employs a distinctive direct-to-consumer model, managing every aspect from development to sales, which allows for competitive pricing and quick product iteration. The company has demonstrated consistent growth, with significant increases in sales and profitability in recent fiscal periods, driven by strategic store expansions in Japan, the United States, China, and Taiwan, as well as a focus on premium products and innovative offerings. Further extending its scope, the company also engages in certain miscellaneous goods and has explored sustainability initiatives within its operations.